Suppr超能文献

使用对照材料对SurePath染色的液基细胞学妇科宫颈样本进行技术外部质量评估——一种新方法。

Technical external quality assessment for SurePath stained liquid-based cytology gynaecological cervical samples using control material--a novel approach.

作者信息

Boucher N A, Rose B G

机构信息

Cervical Screening Wales, Cardiff, UK.

出版信息

Cytopathology. 2009 Jun;20(3):169-75. doi: 10.1111/j.1365-2303.2007.00553.x. Epub 2008 Jul 14.

Abstract

AIMS AND OBJECTIVE

The Technical External Quality Assessment Scheme (TEQA) introduced in Wales is based on NHSCSP publication No 19 [External Quality Assessment Scheme for the Evaluation of Papanicolaou Staining in Cervical Cytology] which sets out the policies and standard operating procedures for the TEQA of Papanicolaou staining of gynaecological cervical samples. As part of a development plan for the TEQA scheme in Wales, the use of a control sample was introduced to the assessment process - a common control sample can provide a consistent assessment parameter independent of the recommended slide selection process [External Quality Assessment Scheme for the Evaluation of Papanicolaou Staining in Cervical Cytology, NHSCSP Publication No 19, February 2004] enabling direct comparison of staining standards for laboratories within the region; this counters selection variation bias, establishing a process that may be more representative of routine staining results.

METHODS

A cervical sample was selected in line with the criteria described in publication 19 [External Quality Assessment Scheme for the Evaluation of Papanicolaou Staining in Cervical Cytology, NHSCSP Publication No 19, February 2004]. Thirteen slides were prepared by the scheme facilitator from this anonymized sample. These control slides were subsequently 'fixed' but not stained, then distributed to the laboratories participating in the TEQA scheme. The slides were stained using their standard regime, then returned to the facilitator for assessment. The slides showed consistent staining with no significant inter-laboratory variation, however, the eosinophilic stained components exhibited an artificial colouration, which slightly altered the expected stained appearance; this was thought to be due to 'cross-reactivity' of the spray fixative with the preserving agent. To address this artefact, a further development of control procedures was devised utilizing a pooled control sample procedure. Residual material from a number of similar samples was pooled and distributed in aliquots to participant laboratories for standard processing and staining; the completed slides were returned to the scheme facilitator for assessment.

RESULTS

The pooled sample slides were assessed at the next scheduled quarterly TEQA assessment. The overall scoring for these samples produced an acceptable level of Papanicolaou staining for 12 of the laboratories - only one laboratory produced a marginal score. The artefactual presentation of eosinophilia was not seen.

DISCUSSION/CONCLUSION: This method of producing control material establishes consistency in the TEQA comparative assessment process, counters selection bias and reduces the time demands associated with slide selection. It may also prove useful in identifying technical problems within laboratories during sample preparation prior to or during staining, including equipment or process faults. This technique is now well established locally as an enhancement of the current TEQA scheme for the assessment of slide staining. We feel that this enhancement could be incorporated as a new initiative in the current National TEQA scheme as a complement to the established selection process.

摘要

目的

威尔士引入的技术外部质量评估计划(TEQA)基于NHSCSP第19号出版物《宫颈细胞学巴氏染色评估外部质量评估计划》,该出版物规定了妇科宫颈样本巴氏染色TEQA的政策和标准操作程序。作为威尔士TEQA计划发展规划的一部分,在评估过程中引入了对照样本——一个通用对照样本可以提供一个独立于推荐玻片选择过程的一致评估参数(《宫颈细胞学巴氏染色评估外部质量评估计划》,NHSCSP第19号出版物,2004年2月),从而能够直接比较该地区各实验室的染色标准;这可以对抗选择变异偏差,建立一个可能更能代表常规染色结果的过程。

方法

根据第19号出版物(《宫颈细胞学巴氏染色评估外部质量评估计划》,NHSCSP第19号出版物,2004年2月)中描述的标准选择一份宫颈样本。计划协调员从该匿名样本中制备了13张玻片。这些对照玻片随后进行了“固定”但未染色,然后分发给参与TEQA计划的实验室。玻片按照其标准流程进行染色,然后返回给协调员进行评估。玻片显示出一致的染色,实验室间无显著差异,然而,嗜酸性染色成分呈现出人为的颜色变化,这略微改变了预期的染色外观;这被认为是由于喷雾固定剂与防腐剂的“交叉反应”所致。为了解决这个假象,设计了一种利用混合对照样本程序的对照程序进一步改进方案。将多个相似样本的剩余材料汇集起来,分成等分发给参与实验室进行标准处理和染色;完成的玻片返回给计划协调员进行评估。

结果

在下次预定的季度TEQA评估中对混合样本玻片进行了评估。这些样本的总体评分显示,12个实验室的巴氏染色水平可接受——只有一个实验室的评分接近临界值。未观察到嗜酸性的假象表现。

讨论/结论:这种制备对照材料的方法在TEQA比较评估过程中建立了一致性,对抗了选择偏差,并减少了与玻片选择相关的时间需求。它还可能有助于在染色前或染色过程中样本制备期间识别实验室内部的技术问题,包括设备或流程故障。这种技术目前在当地已得到充分确立,作为对当前用于玻片染色评估的TEQA计划的一种改进。我们认为,这种改进可以作为一项新举措纳入当前的国家TEQA计划,作为对既定选择过程的补充。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验